Goldman Sachs
CYTR

Goldman Sachs’s CytRx Corp CYTR Stock Holding History

Goldman Sachs’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,947
Closed -$15K – 6964
2017
Q3 		$15K Sell
5,947
-111,297
-95% -$376K ﹤0.01% 6478
2017
Q2 		$441K Buy
117,244
+104,144
+795% +$356K ﹤0.01% 5196
2017
Q1 		$35K Buy
13,100
+9,944
+315% +$25.2K ﹤0.01% 6384
2016
Q4 		$7K Sell
3,156
-1,890
-37% -$5.56K ﹤0.01% 6800
2016
Q3 		$18K Sell
5,046
-5,274
-51% -$24.2K ﹤0.01% 6784
2016
Q2 		$138K Buy
10,320
+7,648
+286% +$127K ﹤0.01% 5958
2016
Q1 		$43K Buy
+2,672
New +$36.5K ﹤0.01% 6501
2015
Q4 		– Sell
-1,906
Closed -$27K – 7680
2015
Q3 		$27K Sell
1,906
-3,828
-67% -$64.8K ﹤0.01% 6969
2015
Q2 		$128K Buy
5,734
+2,712
+90% +$67.9K ﹤0.01% 6477
2015
Q1 		$61K Buy
3,022
+895
+42% +$16.7K ﹤0.01% 6632
2014
Q4 		$35K Sell
2,127
-1,112
-34% -$17.3K ﹤0.01% 6904
2014
Q3 		$49K Buy
3,239
+1,764
+120% +$34.9K ﹤0.01% 6823
2014
Q2 		$37K Sell
1,475
-442
-23% -$10.1K ﹤0.01% 6810
2014
Q1 		$40K Sell
1,917
-1,732
-47% -$61.5K ﹤0.01% 6612
2013
Q4 		$137K Buy
3,649
+3,505
+2,434% +$63.8K ﹤0.01% 6153
2013
Q3 		$3K Buy
+144
New +$2.12K ﹤0.01% 6523

Other funds holding CYTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

Goldman Sachs's CYTR Position: Q4 2017 in Review

Goldman Sachs sold out of CytRx Corp (CYTR) in Q4 2017, closing a stake of 5,947 shares — an estimated $15K sold.

Goldman Sachs first reported a position in CYTR in Q3 2013 and held it in 16 quarters. The position peaked at $441K in Q2 2017. 33 funds tracked by Wall St. Rank hold CYTR as of Q4 2017.

  • Goldman Sachs reported no remaining CytRx Corp position as of Q4 2017 after selling out during the quarter.
  • Goldman Sachs sold 5,947 CytRx Corp shares in Q4 2017, an estimated $15K.
  • Goldman Sachs first reported a position in CytRx Corp in Q3 2013 and held it in 16 quarters.
  • Goldman Sachs's CytRx Corp position peaked at $441K in Q2 2017.
  • 33 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2017.

Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.